Cargando…

Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells

The DNA methylation inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR) is widely used as an anticancer drug for the treatment of leukemia and solid tumors. Gastric cancer (GC) patients who were positive for caudal type homeobox transcription factor 2 (CDX2) expression showed a higher survival rate compare...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, JIAN-FENG, ZHANG, JIAN-GUO, KUAI, XIAO-LING, ZHANG, HONG, JIANG, WEI, DING, WEI-FENG, LI, ZENG-LI, ZHU, HUI-JUN, MAO, ZHEN-BIAO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570199/
https://www.ncbi.nlm.nih.gov/pubmed/23408490
http://dx.doi.org/10.3892/etm.2013.901
_version_ 1782259024462348288
author ZHANG, JIAN-FENG
ZHANG, JIAN-GUO
KUAI, XIAO-LING
ZHANG, HONG
JIANG, WEI
DING, WEI-FENG
LI, ZENG-LI
ZHU, HUI-JUN
MAO, ZHEN-BIAO
author_facet ZHANG, JIAN-FENG
ZHANG, JIAN-GUO
KUAI, XIAO-LING
ZHANG, HONG
JIANG, WEI
DING, WEI-FENG
LI, ZENG-LI
ZHU, HUI-JUN
MAO, ZHEN-BIAO
author_sort ZHANG, JIAN-FENG
collection PubMed
description The DNA methylation inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR) is widely used as an anticancer drug for the treatment of leukemia and solid tumors. Gastric cancer (GC) patients who were positive for caudal type homeobox transcription factor 2 (CDX2) expression showed a higher survival rate compared with those who were CDX2 negative, which suggests that CDX2 performs a tumor suppressor role. However, the molecular mechanisms leading to the inactivation of CDX2 remain unclear. In the present study we demonstrated that the expression levels of CDX2 and DNA methyltransferase enzyme 1 (DNMT1) mRNA were significantly higher in GC compared with distal non-cancerous tissue. The expression of CDX2 mRNA was significantly correlated with Lauren classification, TNM stage and lymph node metastasis. DNMT1 mRNA expression was significantly correlated with TNM stage, pathological differentiation and lymph node metastasis. The expression of CDX2 mRNA was inversely correlated with that of DNMT1 mRNA in GC. Hypermethylation of the CDX2 gene promoter region, extremely low expression levels of CDX2 mRNA and no expression of CDX2 protein were the characteristics observed in MKN-45 and SGC-7901 GC cell lines. Following the treatment of MKN-45 cells with 5-aza-CdR, the hypermethylated CDX2 gene promoter region was demethylated and expression of CDX2 was upregulated, while DNMT1 expression was downregulated. Furthermore, a concentration- and time-dependent growth inhibition as well as increased apoptosis were observed. Caspase-3, −8 and −9 activities increased in a concentration-dependent manner following exposure to different concentrations of 5-aza-CdR. Therefore, our data show that the overexpression of DNMT1 and methylation of the CDX2 gene promoter region is likely to be responsible for CDX2 silencing in GC. 5-Aza-CdR may effectively induce re-expression of the CDX2 gene, inhibit cell proliferation and enhance the caspase-independent apoptosis of MKN-45 cells in vitro.
format Online
Article
Text
id pubmed-3570199
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-35701992013-02-13 Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells ZHANG, JIAN-FENG ZHANG, JIAN-GUO KUAI, XIAO-LING ZHANG, HONG JIANG, WEI DING, WEI-FENG LI, ZENG-LI ZHU, HUI-JUN MAO, ZHEN-BIAO Exp Ther Med Articles The DNA methylation inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR) is widely used as an anticancer drug for the treatment of leukemia and solid tumors. Gastric cancer (GC) patients who were positive for caudal type homeobox transcription factor 2 (CDX2) expression showed a higher survival rate compared with those who were CDX2 negative, which suggests that CDX2 performs a tumor suppressor role. However, the molecular mechanisms leading to the inactivation of CDX2 remain unclear. In the present study we demonstrated that the expression levels of CDX2 and DNA methyltransferase enzyme 1 (DNMT1) mRNA were significantly higher in GC compared with distal non-cancerous tissue. The expression of CDX2 mRNA was significantly correlated with Lauren classification, TNM stage and lymph node metastasis. DNMT1 mRNA expression was significantly correlated with TNM stage, pathological differentiation and lymph node metastasis. The expression of CDX2 mRNA was inversely correlated with that of DNMT1 mRNA in GC. Hypermethylation of the CDX2 gene promoter region, extremely low expression levels of CDX2 mRNA and no expression of CDX2 protein were the characteristics observed in MKN-45 and SGC-7901 GC cell lines. Following the treatment of MKN-45 cells with 5-aza-CdR, the hypermethylated CDX2 gene promoter region was demethylated and expression of CDX2 was upregulated, while DNMT1 expression was downregulated. Furthermore, a concentration- and time-dependent growth inhibition as well as increased apoptosis were observed. Caspase-3, −8 and −9 activities increased in a concentration-dependent manner following exposure to different concentrations of 5-aza-CdR. Therefore, our data show that the overexpression of DNMT1 and methylation of the CDX2 gene promoter region is likely to be responsible for CDX2 silencing in GC. 5-Aza-CdR may effectively induce re-expression of the CDX2 gene, inhibit cell proliferation and enhance the caspase-independent apoptosis of MKN-45 cells in vitro. D.A. Spandidos 2013-03 2013-01-17 /pmc/articles/PMC3570199/ /pubmed/23408490 http://dx.doi.org/10.3892/etm.2013.901 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
ZHANG, JIAN-FENG
ZHANG, JIAN-GUO
KUAI, XIAO-LING
ZHANG, HONG
JIANG, WEI
DING, WEI-FENG
LI, ZENG-LI
ZHU, HUI-JUN
MAO, ZHEN-BIAO
Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title_full Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title_fullStr Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title_full_unstemmed Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title_short Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
title_sort reactivation of the homeotic tumor suppressor gene cdx2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570199/
https://www.ncbi.nlm.nih.gov/pubmed/23408490
http://dx.doi.org/10.3892/etm.2013.901
work_keys_str_mv AT zhangjianfeng reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT zhangjianguo reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT kuaixiaoling reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT zhanghong reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT jiangwei reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT dingweifeng reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT lizengli reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT zhuhuijun reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells
AT maozhenbiao reactivationofthehomeotictumorsuppressorgenecdx2by5aza2deoxycytidineinduceddemethylationinhibitscellproliferationandinducescaspaseindependentapoptosisingastriccancercells